taken together , the results indicate that the marked reduction in the concentration of brain phospholipids caused by treatment of the young rat with u18666a is likely due to decreased phospholipid synthesis secondary to inhibition of several key enzymes in glycerolipid synthesis and , particularly , to inhibition of glycerolphosphate acyltransferase and phosphatidate phosphohydrolase .
C0086045
concentration
C0006104
brain